Teklu B. Legesse, MD

MD from University of Gondar, Ethiopia

Residency in Anatomic and Clinical pathology, University of Maryland Medical Center

Fellowship in Cytopathology, University of Maryland Medical Center

Fellowship in Genitourinay pathology, Johns Hopkins Hospital

My research interests are pathologic diagnosis of diseases of the genitourinary system(prostate, bladder, kedney and testis). I also have an intererst in researches that improve Gyn and non-Gyn cytopathology diagnostics.  

Genitourinary pathology, Cytopathology

PAX8 positivity in nested variant of urothelial carcinoma: a potential diagnostic pitfall.

Legesse T, Matoso A, Epstein JI. Hum Pathol. 2019 Oct 25;94:11-15. doi: 10.1016/j.humpath.2019.09.012.

EP4 and Class III β-Tubulin Expression in Uterine Smooth Muscle Tumors: Implications for Prognosis and Treatment.

Reader J, Harper AK, Legesse T, Staats PN, Goloubeva O, Rao GG, Fulton A, Roque DM. Cancers (Basel). 2019 Oct 18;11(10). pii: E1590. doi: 10.3390/cancers11101590.

Digital image-assisted quantitative nuclear analysis improves diagnostic accuracy of thyroid fine-needle aspiration cytology.

Chain K, Legesse T, Heath JE, Staats PN. Cancer Cytopathol. 2019 Aug;127(8):501-513. doi: 10.1002/cncy.22120. Epub 2019 May 31.

Distinguishing non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) from classic and invasive follicular-variant papillary thyroid carcinomas based on cytologic features.

Legesse T, Parker L, Heath J, Staats PN.  J Am Soc Cytopathol. 2019 Jan - Feb;8(1):11-17. doi: 10.1016/j.jasc.2018.07.004. Epub 2018 Jul 24.

The TNF receptor family member Fn14 is highly expressed in recurrent glioblastoma and in GBM patient-derived xenografts with acquired temozolomide resistance.

Hersh DS, Harder BG, Roos A, Peng S, Heath JE, Legesse T, Kim AJ, Woodworth GF, Tran NL, Winkles JA.  Neuro Oncol. 2018 Sep 3;20(10):1321-1330. doi: 10.1093/neuonc/noy063.

FDG PET/CT of Chromophobe Renal Cell Carcinoma With Sarcomatoid Differentiation.

Lee CH, Kesari V, Legesse T, Chen W. Clin Nucl Med. 2018 May;43(5):367-369. doi: 10.1097/RLU.0000000000002031.

Differential expression of the TWEAK receptor Fn14 in IDH1 wild-type and mutant gliomas.

Hersh DS, Peng S, Dancy JG, Galisteo R, Eschbacher JM, Castellani RJ, Heath JE, Legesse T, Kim AJ, Woodworth GF, Tran NL, Winkles JA. J Neurooncol. 2018 Jun;138(2):241-250. doi: 10.1007/s11060-018-2799-3. Epub 2018 Feb 16.